Exact Mass: 929.1468972000001
Exact Mass Matches: 929.1468972000001
Found 27 metabolites which its exact mass value is equals to given mass value 929.1468972000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Caffeoyl-CoA
C30H42N7O19P3S (929.1468972000001)
Caffeoyl-CoA is an acyl CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of caffeic acid. It is functionally related to a caffeic acid. It is a conjugate acid of a caffeoyl-CoA(4-). An acyl CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of caffeic acid.
(2E)-3-(2,4-Dihydroxyphenyl)prop-2-enoyl-CoA
C30H42N7O19P3S (929.1468972000001)
(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoyl-CoA
C31H46N7O18P3S (929.1832806000001)
(2e,8e)-10-hydroxydeca-2,8-dien-4-ynoyl-coa is an acyl-CoA or acyl-coenzyme A. More specifically, it is a (2E_8E)-10-hydroxydeca-2_8-dien-4-ynoic acid thioester of coenzyme A. (2e,8e)-10-hydroxydeca-2,8-dien-4-ynoyl-coa is an acyl-CoA with 9 fatty acid group as the acyl moiety attached to coenzyme A. Coenzyme A was discovered in 1946 by Fritz Lipmann (Journal of Biological Chemistry (1946) 162 (3): 743–744) and its structure was determined in the early 1950s at the Lister Institute in London. Coenzyme A is a complex, thiol-containing molecule that is naturally synthesized from pantothenate (vitamin B5), which is found in various foods such as meat, vegetables, cereal grains, legumes, eggs, and milk. More specifically, coenzyme A (CoASH or CoA) consists of a beta-mercaptoethylamine group linked to the vitamin pantothenic acid (B5) through an amide linkage and 3-phosphorylated ADP. Coenzyme A is synthesized in a five-step process that requires four molecules of ATP, pantothenate and cysteine. It is believed that there are more than 1100 types of acyl-CoA’s in the human body, which also corresponds to the number of acylcarnitines in the human body. Acyl-CoAs exists in all living species, ranging from bacteria to plants to humans. The general role of acyl-CoA’s is to assist in transferring fatty acids from the cytoplasm to mitochondria. This process facilitates the production of fatty acids in cells, which are essential in cell membrane structure. Acyl-CoAs are also susceptible to beta oxidation, forming, ultimately, acetyl-CoA. Acetyl-CoA can enter the citric acid cycle, eventually forming several equivalents of ATP. In this way, fats are converted to ATP -- or biochemical energy. Acyl-CoAs can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain acyl-CoAs; 2) medium-chain acyl-CoAs; 3) long-chain acyl-CoAs; and 4) very long-chain acyl-CoAs; 5) hydroxy acyl-CoAs; 6) branched chain acyl-CoAs; 7) unsaturated acyl-CoAs; 8) dicarboxylic acyl-CoAs and 9) miscellaneous acyl-CoAs. Short-chain acyl-CoAs have acyl-groups with two to four carbons (C2-C4), medium-chain acyl-CoAs have acyl-groups with five to eleven carbons (C5-C11), long-chain acyl-CoAs have acyl-groups with twelve to twenty carbons (C12-C20) while very long-chain acyl-CoAs have acyl groups with more than 20 carbons. (2e,8e)-10-hydroxydeca-2,8-dien-4-ynoyl-coa is therefore classified as a medium chain acyl-CoA. The oxidative degradation of fatty acids is a two-step process, catalyzed by acyl-CoA synthetase/synthase. Fatty acids are first converted to their acyl phosphate, the precursor to acyl-CoA. The latter conversion is mediated by acyl-CoA synthase. Three types of acyl-CoA synthases are employed, depending on the chain length of the fatty acid. (2e,8e)-10-hydroxydeca-2,8-dien-4-ynoyl-coa, being a medium chain acyl-CoA is a substrate for medium chain acyl-CoA synthase. The second step of fatty acid degradation is beta oxidation. Beta oxidation occurs in mitochondria and, in the case of very long chain acyl-CoAs, the peroxisome. After its formation in the cytosol, (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoyl-CoA is transported into the mitochondria, the locus of beta oxidation. Transport of (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoyl-CoA into the mitochondria requires carnitine palmitoyltransferase 1 (CPT1), which converts (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoyl-CoA into (2E_8E)-10-hydroxydeca-2_8-dien-4-ynoylcarnitine, which gets transported into the mitochondrial matrix. Once in the matrix, (2E_8E)-10-hydroxydeca-2_8-dien-4-ynoylcarnitine is converted back to (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoyl-CoA by CPT2, whereupon beta-oxidation can begin. Beta oxidation of (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoyl-CoA occurs in four steps. First, since (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoyl-CoA is a medium chain acyl-CoA it is the substrate for a medium chain acyl-CoA dehydrogenase, which catalyzes dehydrogenation of (2E,8E)-10-hydroxydeca-2,...
PubChem CID: 46173253; (Acyl-CoA); [M+H]+;
C30H42N7O19P3S (929.1468972000001)
PubChem CID: 46173253; (Acyl-CoA); [M+H]+
C30H42N7O19P3S (929.1468972000001)
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-[2-[(3S)-6-oxo-3-prop-1-en-2-ylheptanoyl]sulfanylethylamino]propyl]amino]butoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate
C31H46N7O18P3S-4 (929.1832806000001)
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-[2-[(3R)-6-oxo-3-prop-1-en-2-ylheptanoyl]sulfanylethylamino]propyl]amino]butoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate
C31H46N7O18P3S-4 (929.1832806000001)
cobalt;3-[(2S,3S,4Z,7S,11S,14Z,17R)-8,13,17-tris(2-carboxylatoethyl)-2,7,12,18-tetrakis(carboxylatomethyl)-2,7,11,17-tetramethyl-3,10-dihydro-1H-corrin-21,23-diid-3-yl]propanoate
C43H42CoN4O16-10 (929.1927671999999)
PubChem CID: 25244038; (Acyl-CoA); [M+H]+
C30H42N7O19P3S (929.1468972000001)
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-4-[[3-[2-(2-hydroxy-4-prop-1-en-2-ylcyclohexanecarbonyl)sulfanylethylamino]-3-oxopropyl]amino]-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate
C31H46N7O18P3S-4 (929.1832806000001)
S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-(2-hydroxyphenyl)-3-oxopropanethioate
C30H42N7O19P3S (929.1468972000001)
S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (Z)-3-hydroxy-3-(2-hydroxyphenyl)prop-2-enethioate
C30H42N7O19P3S (929.1468972000001)
(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoyl-CoA
C31H46N7O18P3S (929.1832806000001)
PubChem CID: 45479645; (Acyl-CoA); [M+H]+
C30H42N7O19P3S (929.1468972000001)
D-2-Keto-3-Deoxygluconate-CoA; (Acyl-CoA); [M+H]+
C27H46N7O21P3S (929.1680256000001)
2,4-Dihydroxy-Trans Cinnamic Acid-CoA; (Acyl-CoA); [M+H]+
C30H42N7O19P3S (929.1468972000001)
Trans-O-Hydroxy-Alpha-Methyl Cinnamate-CoA; (Acyl-CoA); [M+H]+
C31H46N7O18P3S (929.1832806000001)
4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid-CoA; (Acyl-CoA); [M+H]+
trans-caffeoyl-CoA
C30H42N7O19P3S (929.1468972000001)
A caffeoyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of trans-caffeic acid.
(2r)-4-[({[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-n-{2-[(2-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]sulfanyl}ethyl)-c-hydroxycarbonimidoyl]ethyl}-2-hydroxy-3,3-dimethylbutanimidic acid
C30H42N7O19P3S (929.1468972000001)
(2r)-4-[({[(2s,3s,4r,5s)-5-(6-aminopurin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-n-{2-[(2-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]sulfanyl}ethyl)-c-hydroxycarbonimidoyl]ethyl}-2-hydroxy-3,3-dimethylbutanimidic acid
C30H42N7O19P3S (929.1468972000001)